Journal of Palliative MedicineVol. 13, No. 3 Letters to the EditorTreatment of Resistant Depression in Patients with Cancer with Low Doses of Ketamine and DesipramineDuraiyah Thangathurai, Jay Roby, and Peter RoffeyDuraiyah ThangathuraiSearch for more papers by this author, Jay RobySearch for more papers by this author, and Peter RoffeySearch for more papers by this authorPublished Online:23 Feb 2010https://doi.org/10.1089/jpm.2009.0312AboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Treatment of Resistant Depression in Patients with Cancer with Low Doses of Ketamine and Desipramine." , 13(3), p. 235FiguresReferencesRelatedDetailsCited BySingle Subcutaneous Ketamine Dose Followed by Oral Ketamine for Depression Symptoms in Hospice Patients: A Case Series13 April 2021 | Journal of Pain & Palliative Care Pharmacotherapy, Vol. 35, No. 2Substance Use Disorders in Pregnancy and Lactation26 May 2021The Efficacy of Ketamine in the Palliative Care Setting: A Comprehensive Review of the Literature Nathaniel Goldman, Michael Frankenthaler, and Lidia Klepacz3 September 2019 | Journal of Palliative Medicine, Vol. 22, No. 9Psychiatric, behavioral, and cognitive disorders in patients with extracranial cancers23 July 2018 | CNS Spectrums, Vol. 23, No. 6A research study review of effectiveness of treatments for psychiatric conditions common to end-stage cancer patients: needs assessment for future research and an impassioned plea3 April 2018 | BMC Psychiatry, Vol. 18, No. 1Benzodiazepine use, misuse, and abuse: A reviewMental Health Clinician, Vol. 6, No. 3Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim testBehavioural Brain Research, Vol. 279The activation of adenosine monophosphate-activated protein kinase in rat hippocampus contributes to the rapid antidepressant effect of ketamineBehavioural Brain Research, Vol. 253Daily Oral Ketamine for the Treatment of Depression and Anxiety in Patients Receiving Hospice Care: A 28-Day Open-Label Proof-of-Concept Trial Scott A. Irwin, Alana Iglewicz, Richard A. Nelesen, Jessica Y. Lo, Connie H. Carr, Sheilani D. Romero, and Linda S. Lloyd22 July 2013 | Journal of Palliative Medicine, Vol. 16, No. 8Rapid-Acting Glutamatergic Antidepressants: The Path to Ketamine and BeyondBiological Psychiatry, Vol. 73, No. 12Glutamatergic antidepressants27 June 2012Be Prudent of Ketamine in Treating Resistant Depression in Patients with Cancer Chun Yang, Zhi-qiang Zhou, and Jian-jun Yang19 May 2011 | Journal of Palliative Medicine, Vol. 14, No. 5 Volume 13Issue 3Mar 2010 InformationCopyright 2010, Mary Ann Liebert, Inc.To cite this article:Duraiyah Thangathurai, Jay Roby, and Peter Roffey.Treatment of Resistant Depression in Patients with Cancer with Low Doses of Ketamine and Desipramine.Journal of Palliative Medicine.Mar 2010.235-235.http://doi.org/10.1089/jpm.2009.0312Published in Volume: 13 Issue 3: February 23, 2010PDF download